Friday, July 10, 2026

Drug profile · INN

prasugrel

prasugrel (PRASUGREL LUPIN) is a purinergic receptor p2y12 antagonist.

EMA: approved TGA: approved Blood and blood forming organs (B01) B01AC22
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — prasugrel
Class
Blood and blood forming organs (B01)
Route
Patents
0
Programs
1
Data quality
0.83

Quick answer

prasugrel (PRASUGREL LUPIN) is a purinergic receptor p2y12 antagonist.

Key facts

INN prasugrel
Brand PRASUGREL LUPIN
Mechanism Purinergic receptor P2Y12 antagonist
Therapeutic class Blood and blood forming organs (B01)
ATC code B01AC22

Mechanism of action

Purinergic receptor P2Y12 antagonist

Approval history

Authority Status Date
EMA approved
TGA approved

Pipeline programs

  1. ACETYLSALICYLIC ACID, PRASUGREL Approved · Cardiol Therapeutics · St-Elevated Myocardial Infartion

Related & competitor drugs

  1. apixaban Blood and blood forming organs (B01)
  2. berotralstat Blood and blood forming organs (B06)
  3. bivalirudin Blood and blood forming organs (B01)
  4. c1 inhibitor (human) Blood and blood forming organs (B06)
  5. clopidogrel Blood and blood forming organs (B01)
  6. dabigatran etexilate Blood and blood forming organs (B01)

Frequently asked questions

What is prasugrel?

prasugrel (PRASUGREL LUPIN) is a purinergic receptor p2y12 antagonist.

What is the brand name for prasugrel?

PRASUGREL LUPIN is a marketed brand name for prasugrel. Check FDA Drugs@FDA for the current US label holder and prescribing information.